Study: Antibody drug benefits patients with severe asthma

03/5/2009 | BBC

U.K. and Canadian researchers found that mepolizumab, an antibody treatment, effectively reduced asthma attacks and dependence on steroids in patients with severe asthma worsened by eosinophilia, a type of persistent airway inflammation. The antibody drug works by inhibiting the production of eosinophils, white blood cells that can cause eosinophilia when in high levels, one of the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA